Evaluation of breast risk at menopause: what impact on the use of menopausal hormone therapy?

Maturitas · Published 2026-05-25 · DOI 10.1016/j.maturitas.2026.108998

Authors (2)

Márcio Alexandre Hipólito Rodrigues, Anne Gompel

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rodrigues, M., Gompel, A. (2026). Evaluation of breast risk at menopause: what impact on the use of menopausal hormone therapy?. Maturitas. https://doi.org/10.1016/j.maturitas.2026.108998

Related articles

• Examining sleep disturbance as a mediator of the association of vasomotor symptoms with positive and negative emotional well-being in midlife postmenopausal women · Maturitas · 2026 · Same journal
• Urinary and vaginal symptoms in postmenopausal women: a cross-sectional online survey of Greek women · Maturitas · 2026 · Same journal
• Association between TyG-FI and depressive symptom trajectories in middle-aged and older adults: interaction with cognitive function and mediation analysis of sleep quality · Maturitas · 2026 · Same journal
• Metabolic and endocrine factors involved in handgrip strength and dynapenia in postmenopausal women · Maturitas · 2026 · Same journal
• Androgenic profile and cardiometabolic health among post-menopausal women: the Buffalo OsteoPerio study · Maturitas · 2026 · Same journal
• Femtech: hype or evidence-based innovation in women's health? · Maturitas · 2026 · Same journal
• Domain-specific severity of menopausal symptoms and emotional eating in midlife women · Maturitas · 2026 · Same journal
• Breast cancer risk-reducing medications - featuring the new kid, “baby tam” · Maturitas · 2026 · Same journal
• Menopausal hormone therapy and incident benign paroxysmal positional vertigo in postmenopausal women: A prospective cohort study using UK Biobank data · Maturitas · 2026 · Same journal
• Vascular risk at menopause: The importance of a cardio-gynecological program · Maturitas · 2026 · Same journal